Hims & Hers Health Stock Surpasses Analyst Target Price

In a recent report, shares of Hims & Hers Health Inc have crossed above the average 12-month target price set by analysts, signaling potential investor assessments on future performance. The divergence in target prices among analysts may further influence stock behavior.

Date: 15-10-2024

AI Rating: 6

Hims & Hers Health Inc (Symbol: HIMS) has seen its shares trading at $20.50, above the average analyst target price of $20.33. This crossing of the target price can evoke varied responses from analysts, potentially leading to adjustments in target prices based on the company's performance and market conditions.

The report indicates that there are 15 different analyst targets for HIMS, with a standard deviation of $4.186 among them. This variation highlights a spectrum of opinions regarding the stock's future value. The lowest target price mentioned is $13.00, while one analyst predicts a target as high as $28.00.

The breakdown in analyst ratings shows that there are currently 5 strong buy ratings, 2 buy ratings, and 8 hold ratings, with no sell or strong sell ratings. The average rating has remained stable at around 2.2, indicating a generally favorable outlook among analysts. Despite the high degree of analyst endorsements reflected in the average rating, investors might consider the company's fundamentals when determining whether to buy, hold, or sell.

Stocks: HIMS